AAREY DRUGS & PHARMACEUTICALS LTD. Q1 FY26 Results
AAREYDRUGSQ1 FY26 ResultsAnnounced 13 Aug 2025, 05:33 pm| Metric | Value (₹ Cr) | vs Q4 FY25 |
|---|---|---|
| Revenue | 102.21 | 5.5% |
| Total Income | 103.76 | 10.3% |
| Expenditure | 102.03 | 10.5% |
| PBT | 1.73 | 6.4% |
| Net Profit | 1.37 | 191.8% |
| OPM | 1.67% | 6.16pp |
| NPM | 1.32% | 0.91pp |
| EPS | 0.48 | 2300.0% |
Aarey Drugs & Pharmaceuticals Ltd. Announces Q1 2025 Financial Results with 157.53% YoY Revenue Growth
13 Aug 2025 · 13 Aug 2025, 05:43 pm
Summary
Aarey Drugs & Pharmaceuticals Ltd. has announced its Q1 2025 financial results, showing a significant 157.53% YoY revenue growth. The company operates in the manufacturing and trading of drugs & pharmaceuticals and allied activities. The financial results have been reviewed by the Audit Committee and taken on record by the Board of Directors.
Key Highlights
- 1
Q1 2025 revenue growth of 157.53% YoY
- 2
Company operates in Manufacturing and Trading of Drugs & Pharmaceutical and allied activities
- 3
Financial results reviewed by the Audit Committee and taken on record by the Board of Directors
Informational and educational content only. Not investment advice.